Pharmesis International Ltd. provided earnings guidance for the six months ended June 30, 2023. For the six months, the company expects to report a net loss for the unaudited condensed interim financial statements for the six months ended 30 June 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 SGD | -18.37% | -18.37% | -18.37% |
03:30pm | Pharmesis to Issue 4 Million New Shares Under Placement | MT |
Apr. 30 | Pharmesis International Ltd. Approves the Appointment of Seow Yong Teng as Lead Independent Director | CI |
1st Jan change | Capi. | |
---|---|---|
-18.37% | 1.64M | |
+38.00% | 727B | |
-7.52% | 354B | |
+15.91% | 328B | |
-0.26% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.97% | 164B | |
-1.79% | 164B |
- Stock Market
- Equities
- BFK Stock
- News Pharmesis International Ltd.
- Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2023